Astrocytoma grade IV (glioblastoma multiforme) displays 3 subtypes with unique expression profiles of intermediate filament proteins

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2081-2088

  Skalli, Omar ^a   Wilhelmsson, Ulrika ^b   Örndahl, Charlotte ^b   Fekete, Boglarka ^b   Malmgren, Kristina ^b   Rydenhag, Bertil ^b   Pekny, Milos ^b  

^a University of Memphis   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Astrocytoma grade IV; GFAP; Glioblastoma multiforme; Intermediate filament proteins; Nestin; Synemin; Vimentin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN; NESTIN; NEUROFILAMENT PROTEIN; SYNEMIN PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ARTICLE; CANCER GRADING; CANCER SURGERY; CANCER SURVIVOR; CANCER THERAPY; CELL STRESS; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RECORD REVIEW; PROTEIN EXPRESSION; TUMOR LOCALIZATION; TUMOR VOLUME;

ASTROCYTOMA GRADE IV; GFAP; GLIOBLASTOMA MULTIFORME; INTERMEDIATE FILAMENT PROTEINS; NESTIN; SYNEMIN; VIMENTIN;

BRAIN NEOPLASMS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NESTIN; RETROSPECTIVE STUDIES; SPINAL CORD NEOPLASMS; SURVIVAL RATE; SWEDEN; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84884416357     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.03.013     Document Type: Article

References (35)

1. J. Chen, R.M. McKay, and L.F. Parada Malignant glioma: lessons from genomics, mouse models, and stem cells Cell 149 2012 36 47
2. S. Watkins, and H. Sontheimer Unique biology of gliomas: challenges and opportunities Trends Neurosci 35 2012 546 556
3. M. Pekny, and E.B. Lane Intermediate filaments and stress Exp Cell Res 313 2007 2244 2254
4. R. Jing, G. Pizzolato, R.M. Robson, G. Gabbiani, and O. Skalli Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells Glia 50 2005 107 120
5. R. Jing, U. Wilhelmsson, and W. Goodwill Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks J Cell Sci 120 2007 1267 1277
6. M. Pekny, and M. Pekna Astrocyte intermediate filaments in CNS pathologies and regeneration J Pathol 204 2004 428 437
7. M. Pekny, and M. Nilsson Astrocyte activation and reactive gliosis Glia 50 2005 427 434
8. M.J. Herpers, F.C. Ramaekers, J. Aldeweireldt, O. Moesker, and J. Slooff Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas Acta Neuropathol 70 1986 333 339
9. W.K. Yung, M. Luna, and A. Borit Vimentin and glial fibrillary acidic protein in human brain tumors J Neurooncol 3 1985 35 38
10. J.T. Rutka, S.L. Hubbard, K. Fukuyama, K. Matsuzawa, P.B. Dirks, and L.E. Becker Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells Cancer Res 54 1994 3267 3272
11. D.E. Weinstein, M.L. Shelanski, and R.K. Liem Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons J Cell Biol 112 1991 1205 1213
12. J.T. Rutka, and S.L. Smith Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity Cancer Res 53 1993 3624 3631
13. M. Toda, M. Miura, H. Asou, I. Sugiyama, T. Kawase, and K. Uyemura Suppression of glial tumor growth by expression of glial fibrillary acidic protein Neurochem Res 24 1999 339 343
14. M. Pekny, C. Eliasson, and C.L. Chien GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density Exp Cell Res 239 1998 332 343
15. C.M. Jacque, C. Vinner, M. Kujas, M. Raoul, J. Racadot, and N.A. Baumann Determination of glial fibrillary acidic protein (GFAP) in human brain tumors J Neurol Sci 35 1978 147 155
16. N.A. Tascos, J. Parr, and N.K. Gonatas Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system Hum Pathol 13 1982 454 458
17. J.D. van der Meulen, H.J. Houthoff, and E.J. Ebels Glial fibrillary acidic protein in human gliomas Neuropathol Appl Neurobiol 4 1978 177 190
18. U. Wilhelmsson, C. Eliasson, R. Bjerkvig, and M. Pekny Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression Oncogene 22 2003 3407 3411
19. M.G. Mendez, S. Kojima, and R.D. Goldman Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition FASEB J 24 2010 1838 1851
20. W. Domagala, J. Lasota, and A. Dukowicz Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas Am J Pathol 137 1990 1299 1304
21. L.C. Wei, M. Shi, R. Cao, L.W. Chen, and Y.S. Chan Nestin small interfering RNA (siRNA) reduces cell growth in cultured astrocytoma cells Brain Res 1196 2008 103 112
22. W.J. Lu, F. Lan, and Q. He Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis Int J Cancer 128 2011 343 351
23. Y. Pan, R. Jing, A. Pitre, B.J. Williams, and O. Skalli Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton FASEB J 22 2008 3196 3206
24. A. Pitre, N. Davis, M. Paul, A.W. Orr, and O. Skalli Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A Mol Biol Cell 23 2012 1243 1253
25. J.W. Henson, S. Ulmer, and G.J. Harris Brain tumor imaging in clinical trials AJNR Am J Neuroradiol 29 2008 419 424
26. A. Ståhlberg, D. Andersson, and J. Aurelius Defining cell populations with single-cell gene expression profiling: correlations and identification of astrocyte subpopulations Nucleic Acids Res 39 2011 e24
27. L.F. Eng, R.S. Ghirnikar, and Y.L. Lee Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000) Neurochem Res 25 2000 1439 1451
28. M. Pekny, C.B. Johansson, and C. Eliasson Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin J Cell Biol 145 1999 503 514
29. C. Eliasson, C. Sahlgren, and C.H. Berthold Intermediate filament protein partnership in astrocytes J Biol Chem 274 1999 23996 24006
30. U. Wilhelmsson, L. Li, and M. Pekna Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration J Neurosci 24 2004 5016 5021
31. L. Li, A. Lundkvist, and D. Andersson Protective role of reactive astrocytes in brain ischemia J Cereb Blood Flow Metab 28 2008 468 481
32. A. Lundkvist, A. Reichenbach, C. Betsholtz, P. Carmeliet, H. Wolburg, and M. Pekny Under stress, the absence of intermediate filaments from Muller cells in the retina has structural and functional consequences J Cell Sci 117 2004 3481 3488
33. S.L. Macauley, M. Pekny, and M.S. Sands The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis J Neurosci 31 2011 15575 15585
34. A.W. Kraft, X. Hu, and H. Yoon Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice FASEB J 27 2013 187 198
35. E.A. Lepekhin, C. Eliasson, C.H. Berthold, V. Berezin, E. Bock, and M. Pekny Intermediate filaments regulate astrocyte motility J Neurochem 79 2001 617 625